Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 155

1.

Apatite formation in composites of alpha-TCP and degradable polyesters.

Van Den Vreken NM, Pieters IY, De Maeyer EA, Jackers GJ, Schacht EH, Verbeeck RM.

J Biomater Sci Polym Ed. 2006;17(9):953-67.

PMID:
17094635
2.

Low autocrine interferon beta production as a gene therapy approach for AIDS: Infusion of interferon beta-engineered lymphocytes in macaques chronically infected with SIVmac251.

Gay W, Lauret E, Boson B, Larghero J, Matheux F, Peyramaure S, Rousseau V, Dormont D, De Maeyer E, Le Grand R.

Retrovirology. 2004 Sep 25;1:29.

3.

Effect of temperature and immersion on the setting of some calcium phosphate cements.

Driessens FC, Boltong MG, De Maeyer EA, Verbeeck RM, Wenz R.

J Mater Sci Mater Med. 2000 Jul;11(7):453-7.

PMID:
15348011
4.

Isolation, proliferation and differentiation of osteoblastic cells to study cell/biomaterial interactions: comparison of different isolation techniques and source.

Declercq H, Van den Vreken N, De Maeyer E, Verbeeck R, Schacht E, De Ridder L, Cornelissen M.

Biomaterials. 2004 Feb;25(5):757-68.

PMID:
14609664
5.

Altered zincergic innervation of the developing primary somatosensory cortex in monoamine oxidase-A knockout mice.

Brown CE, Seif I, De Maeyer E, Dyck RH.

Brain Res Dev Brain Res. 2003 Apr 14;142(1):19-29.

PMID:
12694941
6.

Surface roughening of glass ionomer cements by neutral NaF solutions.

De Witte AM, De Maeyer EA, Verbeeck RM.

Biomaterials. 2003 May;24(11):1995-2000.

PMID:
12615490
7.

Monoaminergic control of vasopressin and VIP expression in the mouse suprachiasmatic nucleus.

Vacher CM, Frétier P, Créminon C, Seif I, De Maeyer E, Calas A, Hardin-Pouzet H.

J Neurosci Res. 2003 Mar 15;71(6):791-801.

PMID:
12605405
8.

The Ca/P range of nanoapatitic calcium phosphate cements.

Driessens FC, Boltong MG, de Maeyer EA, Wenz R, Nies B, Planell JA.

Biomaterials. 2002 Oct;23(19):4011-7.

PMID:
12162334
9.

Infrared spectrometric study of acid-degradable glasses.

De Maeyer EA, Verbeeck RM, Vercruysse CW.

J Dent Res. 2002 Aug;81(8):552-5.

PMID:
12147746
10.

Type I IFN as a natural adjuvant for a protective immune response: lessons from the influenza vaccine model.

Proietti E, Bracci L, Puzelli S, Di Pucchio T, Sestili P, De Vincenzi E, Venditti M, Capone I, Seif I, De Maeyer E, Tough D, Donatelli I, Belardelli F.

J Immunol. 2002 Jul 1;169(1):375-83.

11.

Enhanced tumor development in mice lacking a functional type I interferon receptor.

Picaud S, Bardot B, De Maeyer E, Seif I.

J Interferon Cytokine Res. 2002 Apr;22(4):457-62.

PMID:
12034028
12.

Altered regulation of the 5-HT system in the brain of MAO-A knock-out mice.

Evrard A, Malagié I, Laporte AM, Boni C, Hanoun N, Trillat AC, Seif I, De Maeyer E, Gardier A, Hamon M, Adrien J.

Eur J Neurosci. 2002 Mar;15(5):841-51.

PMID:
11906526
14.

Regional serotonin metabolism in the brain of transgenic mice lacking monoamine oxidase A.

Popova NK, Gilinsky MA, Amstislavskaya TG, Morosova EA, Seif I, De Maeyer E.

J Neurosci Res. 2001 Nov 1;66(3):423-7.

PMID:
11746359
15.

X-ray diffraction study of acid-degradable glasses.

De Maeyer EA, Verbeeck RM.

J Dent Res. 2001 Aug;80(8):1764-7.

PMID:
11669490
16.

X-ray diffractometric determination of crystalline phase content in bioactive glasses.

De Maeyer EA, Verbeeck RM.

J Biomed Mater Res. 2001 Dec 5;57(3):467-72.

PMID:
11523042
17.

Fluoride release from glass ionomer activated with fluoride solutions.

Dhondt CL, De Maeyer EA, Verbeeck RM.

J Dent Res. 2001 May;80(5):1402-6.

PMID:
11437208
18.

Fluoride release of polyacid-modified composite resins with and without bonding agents.

Vercruysse CW, De Maeyer EA, Verbeeck RM.

Dent Mater. 2001 Jul;17(4):354-8.

PMID:
11356213
19.

Knockout Corner: Knockout mice for monoamine oxidase A.

Seif I, De Maeyer E.

Int J Neuropsychopharmacol. 1999 Sep;2(3):241-243.

PMID:
11281992
20.

Excessive activation of serotonin (5-HT) 1B receptors disrupts the formation of sensory maps in monoamine oxidase a and 5-ht transporter knock-out mice.

Salichon N, Gaspar P, Upton AL, Picaud S, Hanoun N, Hamon M, De Maeyer E, Murphy DL, Mossner R, Lesch KP, Hen R, Seif I.

J Neurosci. 2001 Feb 1;21(3):884-96.

21.

William E. Stewart II.

Marcus PI, Liebert MA, Friedman RM, Tovey MG, Havell EA, Sonnenfeld G, De Maeyer E, Gresser I.

J Interferon Cytokine Res. 2000 Oct;20(10):839-41. No abstract available.

PMID:
11054271
22.

Analysis of the pharmacological and molecular heterogeneity of I(2)-imidazoline-binding proteins using monoamine oxidase-deficient mouse models.

Remaury A, Raddatz R, Ordener C, Savic S, Shih JC, Chen K, Seif I, De Maeyer E, Lanier SM, Parini A.

Mol Pharmacol. 2000 Nov;58(5):1085-90.

PMID:
11040057
23.

Simian immunodeficiency virus resistance of macaques infused with interferon beta-engineered lymphocytes.

Matheux F, Lauret E, Rousseau V, Larghero J, Boson B, Vaslin B, Cheret A, De Maeyer E, Dormont D, LeGrand R.

J Gen Virol. 2000 Nov;81(Pt 11):2741-50.

PMID:
11038387
24.
25.
26.

Conversion of octacalcium phosphate in calcium phosphate cements.

De Maeyer EA, Verbeeck RM, Vercruysse CW.

J Biomed Mater Res. 2000 Oct;52(1):95-106.

PMID:
10906679
27.

Abnormal phrenic motoneuron activity and morphology in neonatal monoamine oxidase A-deficient transgenic mice: possible role of a serotonin excess.

Bou-Flores C, Lajard AM, Monteau R, De Maeyer E, Seif I, Lanoir J, Hilaire G.

J Neurosci. 2000 Jun 15;20(12):4646-56.

28.

Effect of maturation on the fluoride release of resin-modified glass ionomer and polyacid-modified composite resin cements.

Marks LA, Verbeeck RM, De Maeyer EA, Martens LC.

Biomaterials. 2000 Jul;21(13):1373-8.

PMID:
10850931
29.

Fluoride release profiles of mature restorative glass ionomer cements after fluoride application.

De Witte AM, De Maeyer EA, Verbeeck RM, Martens LC.

Biomaterials. 2000 Mar;21(5):475-82.

PMID:
10674812
31.

Transfer of human CD4(+) T lymphocytes producing beta interferon in Hu-PBL-SCID mice controls human immunodeficiency virus infection.

Vieillard V, Jouveshomme S, Leflour N, Jean-Pierre E, Debre P, De Maeyer E, Autran B.

J Virol. 1999 Dec;73(12):10281-8.

32.
33.

Ketanserin and tetrabenazine abolish aggression in mice lacking monoamine oxidase A.

Shih JC, Ridd MJ, Chen K, Meehan WP, Kung MP, Seif I, De Maeyer E.

Brain Res. 1999 Jul 24;835(2):104-12.

PMID:
10415365
34.

Stoichiometry of the leaching process of fluoride-containing aluminosilicate glass-ionomer glasses.

De Maeyer EA, Verbeeck RM, Vercruysse CW.

J Dent Res. 1999 Jul;78(7):1312-8.

PMID:
10403458
35.

Macaque lymphocytes transduced by a constitutively expressed interferon beta gene display an enhanced resistance to SIVmac251 infection.

Matheux F, Le Grand R, Rousseau V, De Maeyer E, Dormont D, Lauret E.

Hum Gene Ther. 1999 Feb 10;10(3):429-40.

PMID:
10048395
37.

Type I interferons.

De Maeyer E, De Maeyer-Guignard J.

Int Rev Immunol. 1998;17(1-4):53-73. Review.

PMID:
9914943
38.

Reactivity of fluoride-containing calcium aluminosilicate glasses used in dental glass-ionomer cements.

De Maeyer EA, Verbeeck RM, Vercruysse CW.

J Dent Res. 1998 Dec;77(12):2005-11.

PMID:
9839789
39.
40.

Fluoride release process of (resin-modified) glass-ionomer cements versus (polyacid-modified) composite resins.

Verbeeck RM, De Maeyer EA, Marks LA, De Moor RJ, De Witte AM, Trimpeneers LM.

Biomaterials. 1998 Mar;19(6):509-19.

PMID:
9645557
41.

Electron-microscopic study of MAOB-containing structures in the nucleus accumbens shell: using MAOA-deficient transgenic mice.

Ikemoto K, Kitahama K, Maeda T, Tokunaga Y, Valatx JL, De Maeyer E, Seif I.

Brain Res. 1997 Oct 10;771(1):163-6.

PMID:
9383021
42.

Monoamine oxidase B (MAOB)-containing structures in MAOA-deficient transgenic mice.

Ikemoto K, Kitahama K, Seif I, Maeda T, De Maeyer E, Valatx JL.

Brain Res. 1997 Oct 10;771(1):121-32.

PMID:
9383015
43.

Interferon beta transduction of peripheral blood lymphocytes from HIV-infected donors increases Th1-type cytokine production and improves the proliferative response to recall antigens.

Vieillard V, Cremer I, Lauret E, Rozenbaum W, Debré P, Autran B, De Maeyer E.

Proc Natl Acad Sci U S A. 1997 Oct 14;94(21):11595-600.

44.

Selective enhancement of emotional, but not motor, learning in monoamine oxidase A-deficient mice.

Kim JJ, Shih JC, Chen K, Chen L, Bao S, Maren S, Anagnostaras SG, Fanselow MS, De Maeyer E, Seif I, Thompson RF.

Proc Natl Acad Sci U S A. 1997 May 27;94(11):5929-33.

45.

Setting reaction and hardening of an apatitic calcium phosphate cement.

Ginebra MP, Fernández E, De Maeyer EA, Verbeeck RM, Boltong MG, Ginebra J, Driessens FC, Planell JA.

J Dent Res. 1997 Apr;76(4):905-12.

PMID:
9126187
46.

[Development of an anti-HIV gene therapy based on the antiviral properties of beta interferon].

De Maeyer E, Vieillard V, Cremer I, Rousseau V, Jacomet C, Debré P, Rozenbaum W, Autran B, Lauret E.

Transfus Clin Biol. 1997;4(3):281-6. Review. French.

PMID:
9264786
47.

Kinetic study of the setting reaction of a calcium phosphate bone cement.

Fernández E, Ginebra MP, Boltong MG, Driessens FC, Ginebra J, De Maeyer EA, Verbeeck RM, Planell JA.

J Biomed Mater Res. 1996 Nov;32(3):367-74.

PMID:
8897141
48.

Fluoride release profiles of restorative glass ionomer formulations.

De Moor RJ, Verbeeck RM, De Maeyer EA.

Dent Mater. 1996 Mar;12(2):88-95.

PMID:
9002849
49.

Effect of K(+) on the Stoichiometry of Carbonated Hydroxyapatite Obtained by the Hydrolysis of Monetite.

De Maeyer EA, Verbeeck RM, Pieters IY.

Inorg Chem. 1996 Feb 14;35(4):857-863.

PMID:
11666257
50.

Supplemental Content

Loading ...
Support Center